Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2007-003971-38-ES
EUCTR2007-003971-38-ES
Active, Not Recruiting
N/A

An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of MontelukastEstudio observacional de seguimiento de pacientes pediátricos que participaron en un estudio previo de montelukast en la bronquiolitis inducida por el virus respiratorio sincitial (VRS)

Merck Sharp & Dohme de España, S.A.0 sites400 target enrollmentNovember 23, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
DrugsSingulair

Overview

Phase
N/A
Intervention
Not specified
Conditions
Not specified
Sponsor
Merck Sharp & Dohme de España, S.A.
Enrollment
400
Status
Active, Not Recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 23, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
Merck Sharp & Dohme de España, S.A.

Eligibility Criteria

Inclusion Criteria

  • •Patient successfully completed Visit 8 of Protocol 272\.
  • •Are the trial subjects under 18?
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years)
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years)
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •Patient has developed or has been diagnosed with any illness or congenital disorder
  • •that could be immediately life threatening (e.g., arrhythmias congenital heart disease,
  • •brittle diabetes,” neoplasia incompletely cured or treated within the last 3 months),
  • •or would pose a restriction on participation or successful completion of the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, Not Recruiting
Phase 1
An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukastasthma and atopic diseasesMedDRA version: 9.1Level: LLTClassification code 10003560Term: Asthma NOSMedDRA version: 9.1Level: LLTClassification code 10003637Term: Atopic
EUCTR2007-003971-38-DEMerck & Co., Inc.400
Active, Not Recruiting
Phase 1
An Observational Follow-Up Study of Pediatric Patients Who Participated in a Previous Respiratory Syncytial Virus (RSV)-Induced Bronchiolitis Study of Montelukastasthma and atopic diseasesMedDRA version: 9.1 Level: LLT Classification code 10003560 Term: Asthma NOSMedDRA version: 9.1 Level: LLT Classification code 10003637 Term: Atopic
EUCTR2007-003971-38-FRaboratoires Merck Sharp & Dohme - Chibret400
Completed
N/A
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)Respiratory Syncytial Virus Bronchiolitis
NCT01140048Organon and Co343
Completed
Phase 4
A prospective pediatric longitudinal evaluation to assess the long-term safety of tacrolimus ointment for the treatment of atopic dermatitis.Atopic Dermatitis10014982
NL-OMON30879Astellas Pharma120
Recruiting
N/A
A prospective observational study in child patients with RSV infectioRSV infection
JPRN-jRCT1030230252Ishiwada Naruhiko100